← Back to Clinical Trials
Recruiting NCT07330622

NCT07330622 Polish Registry of Percutaneous Coronary Intervention for Chronic Total Occlusions

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07330622
Status Recruiting
Phase
Sponsor National Institute of Cardiology, Warsaw, Poland
Condition Coronary Occlusion
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2025-05-21
Primary Completion 2026-05

Trial Parameters

Condition Coronary Occlusion
Sponsor National Institute of Cardiology, Warsaw, Poland
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-05-21
Completion 2026-05

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this observational study is to evaluate the safety, efficacy, and clinical outcomes of percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) in patients treated in contemporary clinical practice in Poland. The main questions it aims to answer are: * What are the rates of procedural success and periprocedural complications of CTO PCI in routine clinical practice? * How do CTO PCI strategies and techniques, intravascular imaging, different treatment strategies, and mechanical circulatory support affect clinical outcomes? * How do clinical outcomes differ among different patient subgroups? * Can artificial intelligence-based analysis predict clinical and quality-of-life outcomes after CTO PCI? Patients undergoing CTO PCI as part of their standard medical care will be prospectively enrolled in a national, multicenter registry, with clinical, procedural, and follow-up data collected to evaluate real-world outcomes.

Eligibility Criteria

Inclusion Criteria: * Patients undergoing CTO PCI based on clinical grounds Exclusion Criteria: * Age \<18 years * Patient's refusal to participate in the registry

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology